quinazolines has been researched along with Diabetes Mellitus, Type 1 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badal, D; Bhadada, SK; Bhansali, A; Bhansali, S; Dutta, P; Mukherjee, S; Sachdeva, N | 1 |
| Matsui, T; Nakashima, S; Takeuchi, M; Yamagishi, SI | 1 |
| Barbera Betancourt, A; Cooke, A; Emery, JL; Okkenhaug, K; Recino, A; Wallberg, M; Wong, FS | 1 |
| Choi, SK; Galán, M; Henrion, D; Kassan, M; Matrougui, K; Partyka, M; Trebak, M | 1 |
| Cetkovic-Cvrlje, M; Ghate, K; Olson, M | 1 |
| Jelsing, J; Klein, T; Mark, M; van Witteloostuijn, SB; Vrang, N | 1 |
| Brenker, K; Choi, K; Durand, CA; Gold, MR; Graves, M; Horwitz, MS; Puri, KD; Richer, MJ; Shanina, I | 1 |
| Cetkovic-Cvrlje, M; Dragt, AL; Liu, XP; Uckun, FM; Vassilev, A | 1 |
| Funk, G; Kornek, GV; Oehler, L; Scheithauer, W; Schwarz, C; Urbauer, E; Wenzel, C | 1 |
| Adams, JW; Soucheray, JA | 1 |
| Huse, K; Leistner, S; Scherbaum, WA; Scholz, GH; Seissler, J; Vieweg, S | 1 |
1 trial(s) available for quinazolines and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effect of Linagliptin on Incretin-axis and Glycaemic Variability in T1DM.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Incretins; Linagliptin; Purines; Quinazolines; Treatment Outcome | 2018 |
10 other study(ies) available for quinazolines and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis.
Topics: Animals; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipeptidyl Peptidase 4; Glycation End Products, Advanced; Humans; Intercellular Adhesion Molecule-1; Kidney; Linagliptin; Male; Purines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2014 |
Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.
Topics: Adenine; Animals; Cell Differentiation; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; T-Lymphocytes | 2016 |
A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.
Topics: Animals; Blotting, Western; Cholagogues and Choleretics; Diabetes Mellitus, Type 1; Endoplasmic Reticulum Stress; ErbB Receptors; Fibrosis; Gene Expression; Heart; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Myocardium; Phosphorylation; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Taurochenodeoxycholic Acid; Transcription Factor CHOP; Tyrphostins; Vasodilation | 2012 |
Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells.
Topics: Animals; Apoptosis; CD4 Lymphocyte Count; Cells, Cultured; Cytoprotection; Diabetes Mellitus, Type 1; Female; Humans; Janus Kinase 3; Mice; Mice, Inbred NOD; Quinazolines; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Up-Regulation | 2012 |
The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Topics: Age of Onset; Animals; Diabetes Mellitus, Type 1; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Female; Insulin; Insulin-Secreting Cells; Linagliptin; Mice; Mice, Inbred NOD; Purines; Quinazolines | 2012 |
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Topics: Adenine; Animals; Autoimmunity; B-Lymphocytes; Diabetes Mellitus, Type 1; Disease Progression; Female; Flow Cytometry; Histocytochemistry; Insulin-Secreting Cells; Mice; Mice, Inbred NOD; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinazolines; Statistics, Nonparametric | 2013 |
Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice.
Topics: Adoptive Transfer; Animals; Cytokines; Diabetes Mellitus, Type 1; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Interleukin-2; Janus Kinase 3; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Milk Proteins; Ovalbumin; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; STAT5 Transcription Factor; T-Lymphocytes; Trans-Activators; Tyrosine | 2003 |
Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse event.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Colonoscopy; Colorectal Neoplasms; Diabetes Complications; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enterocolitis; Fatal Outcome; Female; Gastrointestinal Diseases; Humans; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Thiophenes | 2006 |
Prazosin-induced priapism in a diabetic.
Topics: Adult; Diabetes Mellitus, Type 1; Humans; Hypertension; Male; Prazosin; Priapism; Quinazolines | 1984 |
A simplified procedure for the isolation of immunoglobulins from human serum using a novel type of thiophilic gel at low salt concentration.
Topics: Animals; Autoantibodies; Chromatography, Affinity; Diabetes Mellitus, Type 1; Fluorescent Antibody Technique, Indirect; Graves Disease; Humans; Immunoglobulins; Iodide Peroxidase; Islets of Langerhans; Osmolar Concentration; Protein Binding; Quinazolines; Radioimmunoassay; Sepharose; Sulfones; Thyroiditis, Autoimmune | 1998 |